UBS Group’s CollPlant Biotechnologies OPHI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | – | Sell |
-104
| Closed | -$361 | – | 11239 |
|
|
2026
Q2 | $361 | Buy |
104
+94
| +940% | +$362 | ﹤0.01% | 9897 |
|
|
2026
Q1 | $51 | Buy |
+10
| New | +$101 | ﹤0.01% | 10201 |
|
|
2025
Q2 | – | Sell |
-2,407
| Closed | -$62.1K | – | 10310 |
|
|
2025
Q1 | $62.1K | Buy |
2,407
+186
| +8% | +$6.55K | ﹤0.01% | 7414 |
|
|
2024
Q4 | $79.9K | Buy |
2,221
+1,026
| +86% | +$41.7K | ﹤0.01% | 7009 |
|
|
2024
Q3 | $59.3K | Buy |
1,195
+481
| +67% | +$23.6K | ﹤0.01% | 6703 |
|
|
2024
Q2 | $35.5K | Buy |
714
+236
| +49% | +$13.1K | ﹤0.01% | 6955 |
|
|
2024
Q1 | $25.6K | Buy |
+478
| New | +$25.8K | ﹤0.01% | 6806 |
|
|
2023
Q4 | – | Sell |
-569
| Closed | -$31.7K | – | 9365 |
|
|
2023
Q3 | $31.7K | Sell |
569
-86
| -13% | -$5.69K | ﹤0.01% | 6568 |
|
|
2023
Q2 | $53.4K | Sell |
655
-145
| -18% | -$10.6K | ﹤0.01% | 6438 |
|
|
2023
Q1 | $56.2K | Buy |
800
+96
| +14% | +$9.42K | ﹤0.01% | 6364 |
|
|
2022
Q4 | $58.8K | Sell |
704
-213
| -23% | -$14.6K | ﹤0.01% | 6606 |
|
|
2022
Q3 | $62K | Buy |
917
+166
| +22% | +$13.5K | ﹤0.01% | 6134 |
|
|
2022
Q2 | $60K | Buy |
751
+408
| +119% | +$37.5K | ﹤0.01% | 5777 |
|
|
2022
Q1 | $38K | Sell |
343
-184
| -35% | -$20.2K | ﹤0.01% | 6753 |
|
|
2021
Q4 | $86K | Buy |
+527
| New | +$94K | ﹤0.01% | 6449 |
|
|
2021
Q3 | – | Sell |
-201
| Closed | -$43K | – | 9586 |
|
|
2021
Q2 | $43K | Buy |
201
+83
| +70% | +$13.3K | ﹤0.01% | 6568 |
|
|
2021
Q1 | $16K | Buy |
+118
| New | +$17.8K | ﹤0.01% | 7564 |
|
|
2020
Q4 | – | Sell |
-27
| Closed | -$2K | – | 8417 |
|
|
2020
Q3 | $2K | Sell |
27
-43
| -61% | -$3.87K | ﹤0.01% | 7640 |
|
|
2020
Q2 | $7K | Buy |
+70
| New | +$7.21K | ﹤0.01% | 7213 |
|
|
2019
Q4 | – | Sell |
-530
| Closed | -$21K | – | 8127 |
|
|
2019
Q3 | $21K | Buy |
530
+352
| +198% | +$14.2K | ﹤0.01% | 6704 |
|
|
2019
Q2 | $8K | Buy |
+178
| New | +$9.34K | ﹤0.01% | 7177 |
|
|
2019
Q1 | – | Sell |
-332
| Closed | -$14K | – | 7765 |
|
|
2018
Q4 | $14K | Sell |
332
-651
| -66% | -$33.9K | ﹤0.01% | 7031 |
|
|
2018
Q3 | $50K | Buy |
+983
| New | +$54.2K | ﹤0.01% | 6160 |
|
Other funds holding OPHI
UBS Group's OPHI Position: Q3 2026 in Review
UBS Group sold out of CollPlant Biotechnologies (OPHI) in Q3 2026, closing a stake of 104 shares — an estimated $361 sold.
UBS Group first reported a position in OPHI in Q3 2018 and held it in 23 quarters. The position peaked at $86K in Q4 2021. 7 funds tracked by Wall St. Rank hold OPHI as of Q3 2026.
- UBS Group reported no remaining CollPlant Biotechnologies position as of Q3 2026 after selling out during the quarter.
- UBS Group sold 104 CollPlant Biotechnologies shares in Q3 2026, an estimated $361.
- UBS Group first reported a position in CollPlant Biotechnologies in Q3 2018 and held it in 23 quarters.
- UBS Group's CollPlant Biotechnologies position peaked at $86K in Q4 2021.
- 7 funds tracked by Wall St. Rank held CollPlant Biotechnologies as of Q3 2026.
Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.